Volume 19, Number 6—June 2013
Dispatch
Human Papillomavirus Genital Infections among Men, China, 2007–2009
Table 1
Genotype† | Genus and species | Positive, no. (%)‡ |
---|---|---|
Oncogenic type§ | 140 (35.8) | |
HPV-16 | Alpha-9 | 68 (17.4) |
HPV-18 | Alpha-7 | 28 (7.2) |
HPV-58 | Alpha-9 | 13 (3.3) |
HPV-33 | Alpha-9 | 8 (2.0) |
HPV-45 | Alpha-7 | 5 (1.3) |
HPV-52 | Alpha-9 | 4 (1.0) |
HPV-66 | Alpha-6 | 4 (1.0) |
HPV-35 | Alpha-9 | 3 (0.8) |
HPV-68 | Alpha-7 | 3 (0.8) |
HPV-31 | Alpha-9 | 1 (0.3) |
HPV-51 | Alpha-5 | 1 (0.3) |
HPV-56 | Alpha-6 | 1 (0.3) |
HPV-59 |
Alpha-7 |
1 (0.3) |
Nononcogenic type¶ | 251 (64.2) | |
HPV-3 | Alpha-2 | 64 (16.4) |
HPV-57 | Alpha-4 | 31 (7.9) |
HPV-87 | Alpha-3 | 18 (4.6) |
HPV-81 | Alpha-3 | 17 (4.3) |
HPV-11 | Alpha-10 | 15 (3.8) |
HPV-67 | Alpha-9 | 12 (3.1) |
HPV-90 | Alpha-14 | 12 (3.1) |
HPV-43 | Alpha-8 | 11 (2.8) |
HPV-75 | Beta-3 | 10 (2.6) |
HPV-54 | Alpha-13 | 9 (2.3) |
HPV-91 | Alpha-8 | 9 (2.3) |
HPV-94 | Alpha-2 | 8 (2.0) |
HPV-6 | Alpha-10 | 6 (1.5) |
HPV-30 | Alpha-6 | 6 (1.5) |
HPV-27 | Alpha-4 | 5 (1.3) |
HPV-40 | Alpha-8 | 5 (1.3) |
HPV-10 | Alpha-2 | 4 (1.0) |
HPV-62 | Alpha-3 | 2 (0.5) |
HPV-74 | Alpha-10 | 2 (0.5) |
HPV-84 | Alpha-3 | 2 (0.5) |
HPV-7 | Alpha-8 | 1 (0.3) |
HPV-29 | Alpha-2 | 1 (0.3) |
HPV-77 |
Alpha-2 |
1 (0.3) |
Total | 391 (100) |
*HPV, human papillomavirus; Alpha, Alphapapillomovirus; Beta, Betapapillomavirus.
†Of 391 HPV-positive specimens, 15 displayed ambiguous typing signals by direct sequencing of PCR product. Infection with >1 HPV type was detected in only 3 of 15 specimens that were tested by cloning and sequencing; the predominant type is shown.
‡Proportion.
§Oncogenic types tested in this study included HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, -56, -58, -59, and -66.
¶On the basis of latest published literature and our knowledge of the detection method of HPV DNA adopted in this study (SPF1/GP6+ mediated PCR and sequencing), nononcogenic types that could be tested for were HPV-3, -6, -7, -10, -11, -26, -27, -29, -30, -32, -37, -40, -42, -43, -44, -53, -54, -55, -57, -61, -62, -67, -68, -69, -70, -72, -74, -75, -77, -81, -82, -84, -85, -87, -90, -91, and -94.
1These authors contributed equally to this article.